MYST inhibitors

CR20260123APending Publication Date: 2026-06-15ISOSTERIX INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CR202600123
Authority / Receiving Office: CR · CR
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-09-26
Filing Date: 2024-09-26
Publication Date: 2026-06-15

Application Information

Patent Timeline

26 Sep 2024

Priority

26 Sep 2024

Application

CR202600123

15 Jun 2026

Publication

CR20260123A

IPC: C07D413/14; A61K31/423; A61K31/424; A61K31/4439; A61P35/00; C07D413/06; C07D413/12; C07D417/12; C07D417/14; C07D487/04; C07D498/04; C07D515/08; C07D519/00

CPC: C07D498/04; A61P35/00; C07D413/14; C07D417/12; C07D413/06; C07D413/12; A61K31/4162; A61K31/4178

Inventors: RAI Roopa; PANDEY Anjali

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

Provided herein are compounds that are MYST inhibitors, and pharmaceutically acceptable derivatives thereof. Also provided are pharmaceutical compositions containing the compounds and methods of using the compounds for treating a subject with a hyperproliferative disease including cancer.

Need to check novelty before this filing date? Find Prior Art